Jan Engl

Jan Engl is a Senior Marketing Manager with extensive experience in introducing innovative drugs to the Czech market, having successfully launched eight products in ten years, including three first-in-class concepts. They have led teams of customer managers in the Specialty Care environment and driven complex alliance projects between pharmaceutical companies, notably BMS and AstraZeneca in diabetology. With past roles ranging from Product Manager for Novo Nordisk to Business Unit Director at Ipsen, Jan has a deep knowledge of diabetology and immuno-oncology and practical implementation of multichannel marketing strategies. They served as Managing Director of a nonprofit organization supporting patients, further enhancing their understanding of patient needs. Jan holds an RNDr degree in Biochemistry from Univerzita Karlova v Praze.